Niagen Bioscience Statistics
NASDAQ: NAGEHealth Care Medicinal Chemicals and Botanical Products USD
1.84-0.03 (-1.60%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Niagen Bioscience by the numbers
Niagen Bioscience has a market capitalization of $145.7 million based on 79.20M shares outstanding. Its trailing P/E ratio is 15.3. The stock trades 27.8% below its 50-day average and 49.3% below its 200-day average.
Average daily trading volume is 522.66K shares, or about $961,698 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NAGE valuation vs. peer median
| Metric | NAGE | Peer median | Difference |
|---|---|---|---|
| Market cap | $145.72M | $155.05M | -6% |
| Avg. volume | 522.66K | 170.16K | +207% |
Peer median across 8 companies: GLAS, CGC, MDWD, ISPR, FTLF, USNA, BTMD, ACB.
Valuation
- Market cap
- $145.72M
- P/E (TTM)
- 15.33
- Price / sales (latest FY)
- 1.13
- EPS (TTM)
- $0.12
- Shares outstanding
- 79.20M
Price and trading
- Previous close
- 1.87
- Open
- 1.84
- Day range
- 1.79 – 1.86
- 52-week range
- 1.79 – 7.11
- 52-week change
- -73.26%
- Beta
- —
- Volume
- 1.39M
- Average volume
- 522.66K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 145.72M
- Pe
- 15.33
- Forward Pe
- -23.00
- Eps
- 0.12
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.11
- Week52 Low
- 1.79
- Avg Volume
- 522.66K
- Shares Outstanding
- 79.20M
- Ma50
- 2.55
- Ma200
- 3.63
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -74.12%
- Pct From52w Low
- 2.79%